Elevated Levels of Soluble Interleukin-2 Receptors in Multiple Sclerosis

  • Steven J. Greenberg
  • , Luisa Marcon
  • , Barrie J. Hurwitz
  • , Thomas A. Waldmann
  • , David L. Nelson
  • , John L. Trotter
  • , Roel C. Van Der Veen
  • , David B. Clifford

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: The expansion of activated, antigen-reactive T-cell populations is dependent on the sequential induction and expression of interleukin-2 (T-cell growth factor) and the interleukin-2 receptor, and the subsequent binding of interleukin-2 to its high-affinity membrane receptor. In a letter in the May 5 issue,1 Trotter and colleagues have shown elevated serum levels of interleukin-2 in patients with chronic progressive multiple sclerosis. Their findings may reflect a state of ongoing lymphocyte activation, suggesting a commensurate induction and expression of interleukin-2 receptor on circulating T lymphocytes. The high-affinity interleukin-2 receptor is composed of at least two different interleukin-2–binding peptides —.

Original languageEnglish
Pages (from-to)1019-1020
Number of pages2
JournalNew England Journal of Medicine
Volume319
Issue number15
DOIs
StatePublished - Oct 13 1988

Fingerprint

Dive into the research topics of 'Elevated Levels of Soluble Interleukin-2 Receptors in Multiple Sclerosis'. Together they form a unique fingerprint.

Cite this